Otsuka Sues Orchid Pharma to Halt Generic Abilify
Otsuka Pharmaceutical Co. Ltd. has hit Indian drug maker Orchid Pharma Ltd. and its subsidiaries with two patent suits in New Jersey federal court over generic versions of the high-selling antipsychotic...To view the full article, register now.
Already a subscriber? Click here to view full article